Michael Rudnicki
Fondatore presso SATELLOS BIOSCIENCE INC.
Patrimonio netto: 1 M $ in data 30/04/2024
Posizioni attive di Michael Rudnicki
Società | Posizione | Inizio | Fine |
---|---|---|---|
SATELLOS BIOSCIENCE INC. | Fondatore | 01/01/2018 | - |
Corporate Officer/Principal | - | - | |
Direttore/Membro del Consiglio | - | 05/12/2021 | |
Direttore Tecnico/Scientifico/R&S | 01/05/2018 | - | |
University of Ottawa | Corporate Officer/Principal | - | - |
Ottawa Hospital Research Institute
Ottawa Hospital Research Institute Hospital/Nursing ManagementHealth Services The Ottawa Hospital Research Institute is based in Ottawa, CA. The Canadian company provides world-class care with compassionate people. | Corporate Officer/Principal | - | - |
Stem Cell Network | Corporate Officer/Principal | - | - |
Storia della carriera di Michael Rudnicki
Precedenti posizioni note di Michael Rudnicki
Società | Posizione | Inizio | Fine |
---|---|---|---|
Verio Therapeutics, Inc.
Verio Therapeutics, Inc. BiotechnologyHealth Technology Part of Fate Therapeutics, Inc., Verio Therapeutics, Inc. is a Canadian pharmaceutical company that manufactures products for activating endogenous stem cells. The company is based in Ottawa, Canada. Verio Therapeutics was acquired by Fate Therapeutics, Inc. on April 08, 2010. The company was founded by Frank Gleeson, Michael Rudnicki. | Fondatore | - | - |
The Ontario Institute For Regenerative Medicine
The Ontario Institute For Regenerative Medicine Miscellaneous Commercial ServicesCommercial Services The Ontario Institute For Regenerative Medicine provides stem cell and regenerative medicine research services. The company was founded by on November 25, 2014 and is headquartered in Toronto, Canada. | Direttore/Membro del Consiglio | - | - |
Satellos Bioscience, Inc. /Old/
Satellos Bioscience, Inc. /Old/ BiotechnologyHealth Technology Satellos Bioscience, Inc. is a regenerative medicine company. The firm is dedicated to developing novel therapeutics that stimulates or restore muscle regeneration in severe disorders. The company focuses on the discovery that dysregulated muscle stem-cell polarity a process that balances replenishment of muscle stem cells and production of specialized tissue cells can lead to the inability of the body to properly repair and regenerate muscle throughout life. Its lead program is focused on developing an oral therapeutic drug for Duchenne muscular dystrophy that serves to correct this dysregulation which the firm has identified as a root cause of the progressive nature of this disease. Satellos believes defects in muscle regeneration play a critical underlying role in numerous muscle disorders spanning rare diseases through to mass market indications. It applies its proprietary MyoReGenXTM discovery platform to identify regulatory pathways and drug candidates to treat muscle disorders where stem cell polarity is dysregulated. Satellos also maintains the rights to two clinical stage legacy assets as a result of the reverse takeover of iCo Therapeutics Inc.: iCo-008 for potential use in eotaxin-1 mediated indications and an oral Amphotericin B delivery system. The company was founded by Frank Gleeson and Michael Rudnicki in 2018 and is headquartered in Toronto, Canada. | Direttore/Membro del Consiglio | 01/01/2018 | - |
Direttore Tecnico/Scientifico/R&S | 01/01/2018 | - | |
Fondatore | 01/01/2018 | - | |
FATE THERAPEUTICS, INC. | Fondatore | 27/04/2007 | - |
Formazione di Michael Rudnicki
University of Ottawa | Doctorate Degree |
Statistiche
Distribuzione geografica
Canada | 8 |
Stati Uniti | 2 |
Posizioni
Founder | 4 |
Corporate Officer/Principal | 4 |
Director/Board Member | 3 |
Settori
Health Technology | 5 |
Consumer Services | 2 |
Health Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Società quotate in Borsa | 2 |
---|---|
FATE THERAPEUTICS, INC. | Health Technology |
SATELLOS BIOSCIENCE INC. | Health Technology |
Aziende private | 5 |
---|---|
Ottawa Hospital Research Institute
Ottawa Hospital Research Institute Hospital/Nursing ManagementHealth Services The Ottawa Hospital Research Institute is based in Ottawa, CA. The Canadian company provides world-class care with compassionate people. | Health Services |
The Ontario Institute For Regenerative Medicine
The Ontario Institute For Regenerative Medicine Miscellaneous Commercial ServicesCommercial Services The Ontario Institute For Regenerative Medicine provides stem cell and regenerative medicine research services. The company was founded by on November 25, 2014 and is headquartered in Toronto, Canada. | Commercial Services |
Satellos Bioscience, Inc. /Old/
Satellos Bioscience, Inc. /Old/ BiotechnologyHealth Technology Satellos Bioscience, Inc. is a regenerative medicine company. The firm is dedicated to developing novel therapeutics that stimulates or restore muscle regeneration in severe disorders. The company focuses on the discovery that dysregulated muscle stem-cell polarity a process that balances replenishment of muscle stem cells and production of specialized tissue cells can lead to the inability of the body to properly repair and regenerate muscle throughout life. Its lead program is focused on developing an oral therapeutic drug for Duchenne muscular dystrophy that serves to correct this dysregulation which the firm has identified as a root cause of the progressive nature of this disease. Satellos believes defects in muscle regeneration play a critical underlying role in numerous muscle disorders spanning rare diseases through to mass market indications. It applies its proprietary MyoReGenXTM discovery platform to identify regulatory pathways and drug candidates to treat muscle disorders where stem cell polarity is dysregulated. Satellos also maintains the rights to two clinical stage legacy assets as a result of the reverse takeover of iCo Therapeutics Inc.: iCo-008 for potential use in eotaxin-1 mediated indications and an oral Amphotericin B delivery system. The company was founded by Frank Gleeson and Michael Rudnicki in 2018 and is headquartered in Toronto, Canada. | Health Technology |
Stem Cell Network | |
Verio Therapeutics, Inc.
Verio Therapeutics, Inc. BiotechnologyHealth Technology Part of Fate Therapeutics, Inc., Verio Therapeutics, Inc. is a Canadian pharmaceutical company that manufactures products for activating endogenous stem cells. The company is based in Ottawa, Canada. Verio Therapeutics was acquired by Fate Therapeutics, Inc. on April 08, 2010. The company was founded by Frank Gleeson, Michael Rudnicki. | Health Technology |
- Borsa valori
- Insiders
- Michael Rudnicki
- Esperienza